S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Perceptive Advisors/Q2 2026

Perceptive Advisors

Periodo: Q2 2026 · Depositato: 2026-08-14
Vedi su SEC EDGAR
AUM
$6.66B
Valore totale del portafoglio
Posizioni
109
Titoli dichiarati
Prima Posizione
PRAX
10.2% $681.6M
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2026-08-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
PRAXPRAXIS PRECISION MEDICINES I$681.6M10.23%$334.79$366.81+9.6%
10.2%
SYRESPYRE THERAPEUTICS INC$383.5M5.76%$88.78$103.63+16.7%
5.8%
CELCCELCUITY INC$334.5M5.02%$104.62$92.00-12.1%
5.0%
ASNDASCENDIS PHARMA A/S$310.4M4.66%$266.72$248.50-6.8%
4.7%
RYTMRHYTHM PHARMACEUTICALS INC$287.2M4.31%$111.03$115.48+4.0%
4.3%
ROIVROIVANT SCIENCES LTD$286.1M4.30%$35.39$36.20+2.3%
4.3%
RLAYRELAY THERAPEUTICS INC$263.9M3.96%$18.71$19.86+6.2%
4.0%
TVTXTRAVERE THERAPEUTICS INC$213.2M3.20%$56.81$62.14+9.4%
3.2%
KARDIGAN INC$195.6M2.94%
2.9%
NUVLNUVALENT INC$195.2M2.93%
2.9%
EWTXEDGEWISE THERAPEUTICS INC$177.7M2.67%$40.63$44.17+8.7%
2.7%
APGEAPOGEE THERAPEUTICS INC$173.6M2.61%$132.73$134.55+1.4%
2.6%
AMLXAMYLYX PHARMACEUTICALS INC$149.7M2.25%$17.96$21.63+20.4%
2.3%
MGTXMEIRAGTX HLDGS PLC$145.7M2.19%$13.51$13.52+0.1%
2.2%
ORKAORUKA THERAPEUTICS INC$128.0M1.92%$95.17$111.04+16.7%
1.9%
INBXINHIBRX BIOSCIENCES INC$123.0M1.85%$94.75$88.37-6.7%
1.9%
PTGXPROTAGONIST THERAPEUTICS INC$120.4M1.81%$122.58$155.10+26.5%
1.8%
SLDBSOLID BIOSCIENCES INC$119.0M1.79%$9.99$9.20-7.9%
1.8%
ZYMEZYMEWORKS INC$109.3M1.64%$26.14$25.12-3.9%
1.6%
TNGXTANGO THERAPEUTICS INC$105.6M1.58%$31.26$25.60-18.1%
1.6%
IMTXIMMATICS N.V$105.2M1.58%$10.13$9.44-6.8%
1.6%
NRIXNURIX THERAPEUTICS INC$104.8M1.57%$24.26$27.05+11.5%
1.6%
BCRXBIOCRYST PHARMACEUTICALS INC$103.1M1.55%$10.00$9.74-2.6%
1.6%
RVMDREVOLUTION MEDICINES INC$98.8M1.48%$187.28$203.71+8.8%
1.5%
AVLNAVALYN PHARMACEUTICALS INC$88.1M1.32%$32.92$39.25+19.2%
1.3%
MRNAPUTMODERNA INC$70.0M1.05%$70.03$63.32-9.6%
1.1%
DYNDYNE THERAPEUTICS INC$59.7M0.90%$22.21$25.70+15.7%
0.9%
BIIBBIOGEN INC$59.7M0.90%$216.06$209.83-2.9%
0.9%
IMVTIMMUNOVANT INC$52.3M0.79%$38.53$41.82+8.5%
0.8%
UNHUNITEDHEALTH GROUP INC$48.5M0.73%$415.63$401.73-3.3%
0.7%

Attività Trimestre su Trimestre

Q2 2026 vs. Q1 2026

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
ASNDASCENDIS PHARMA A/S$310.4M-6.8%
KARDIGAN INC$195.6M
AVLNAVALYN PHARMACEUTICALS INC$88.1M+19.2%
BIIBBIOGEN INC$59.7M-2.9%
UNHUNITEDHEALTH GROUP INC$48.5M-3.3%
XBIPUTSPDR SERIES TRUST$47.5M
CRLCHARLES RIV LABS INTL INC$31.8M
EYPTPUTEYEPOINT INC$28.6M

Posizioni Chiuse (8)

TickerEmittenteNozionaleDal Deposito
ASNDASCENDIS PHARMA A/S$350.3M-6.8%
CNTACENTESSA PHARMACEUTICALS PLC$208.9M
ENGNENGENE HOLDINGS INC$39.7M
DAWNDAY ONE BIOPHARMACEUTICALS I$37.6M
DRUGBRIGHT MINDS BIOSCIENCES INC$27.6M
BLTEBELITE BIO INC$24.2M
EVMNEVOMMUNE INC$10.3M
NMRANEUMORA THERAPEUTICS INC.$9.9M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ADPTADAPTIVE BIOTECHNOLOGIES COR$24.0M+698.2%
CORTCORCEPT THERAPEUTICS INC$32.6M+696.8%
TNGXTANGO THERAPEUTICS INC$88.7M+317.9%-18.1%
ADGMADAGIO MED HLDGS INC$2.1M+161.2%
SRZNSURROZEN INC$6.4M+119.7%
IRTCIRHYTHM HOLDINGS INC$14.2M+113.1%
RVMDREVOLUTION MEDICINES INC$73.7M+104.0%+8.8%
EOLSEVOLUS INC$11.8M+91.1%

Ridotte (8)

TickerEmittenteNozionaleVar. Azioni
GHGUARDANT HEALTH INC$-21.5M-86.2%
ABVXABIVAX SA$-26.8M-77.5%
ADMAADMA BIOLOGICS INC$-3.3M-75.7%
TWSTTWIST BIOSCIENCE CORP$-3.3M-75.5%
AXGNAXOGEN INC$-11.7M-64.5%
CPIXCUMBERLAND PHARMACEUTICALS I$-0.0M-50.8%
VRDNVIRIDIAN THERAPEUTICS INC$-12.2M-50.3%
PHATPHATHOM PHARMACEUTICALS INC$-4.5M-42.5%
Torna agli Hedge Fund
Perceptive Advisors Q2 2026 13F Filing — Holdings & Portfolio | MarketsFN